Systematic Review of the Treatment of Persistent Hyperparathyroidism Following Kidney Transplantation
Chronic kidney disease–mineral and bone disorder is one of the complications associated with chronic kidney disease. About 10–50% of patients following kidney transplantation have persistent hyperparathyroidism. Hypercalcaemic hyperparathyroidism has a negative impact on the kidney transplant outcom...
Main Authors: | Miłosz Miedziaszczyk, Katarzyna Lacka, Oskar Tomczak, Aleksander Bajon, Marta Primke, Ilona Idasiak-Piechocka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/1/25 |
Similar Items
-
Predictors of persistent post transplant hyperparathyroidism (HPTx)
by: Luiz Roberto Sousa Ulisses, et al.
Published: (2015-01-01) -
Long-term Outcomes of Parathyroidectomy in Kidney Transplant Recipients with Persistent Hyperparathyroidism
by: Po-Yu Tseng, et al.
Published: (2015-07-01) -
Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients – A review
by: Miłosz Miedziaszczyk, et al.
Published: (2023-10-01) -
Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism
by: Francisco José Borrego Utiel, et al.
Published: (2015-07-01) -
Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
by: Josep M. Cruzado, et al.
Published: (2018-01-01)